0001553350-22-000020.txt : 20220106 0001553350-22-000020.hdr.sgml : 20220106 20220106190056 ACCESSION NUMBER: 0001553350-22-000020 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20211220 FILED AS OF DATE: 20220106 DATE AS OF CHANGE: 20220106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Domingo Angelita Rebamontan CENTRAL INDEX KEY: 0001903119 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14942 FILM NUMBER: 22516114 MAIL ADDRESS: STREET 1: 1431 MADISON ST. CITY: TUSTIN STATE: CA ZIP: 92782 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PRO DEX INC CENTRAL INDEX KEY: 0000788920 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 841261240 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 2361 MCGAW AVENUE CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 949-769-3231 MAIL ADDRESS: STREET 1: 2361 MCGAW AVENUE CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: PRO-DEX, INC. DATE OF NAME CHANGE: 20151110 FORMER COMPANY: FORMER CONFORMED NAME: CONTEXT CAPITAL FUNDS DATE OF NAME CHANGE: 20151104 FORMER COMPANY: FORMER CONFORMED NAME: PRO DEX INC DATE OF NAME CHANGE: 19920703 3 1 ownership.xml X0206 3 2021-12-20 0 0000788920 PRO DEX INC PDEX 0001903119 Domingo Angelita Rebamontan 2361 MCGAW AVENUE IRVINE CA 92614 1 0 0 0 Common Stock 7011 D Stock Option (Right to buy) 27.50 2021-07-01 2031-07-01 Common Stock 4250 D Stock Option (Right to buy) 39.00 2022-07-01 2032-07-01 Common Stock 4250 D Stock Option (Right to buy) 42.00 2024-07-01 2034-07-01 Common Stock 4250 D Stock Option (Right to buy) 47.50 2028-07-01 2038-07-01 Common Stock 4250 D Stock Option (Right to buy) 50.00 2030-07-01 2040-07-01 Common Stock 4250 D Performance Award 0 2022-07-01 Common Stock 5800 D Performance Award 0 2024-07-01 Common Stock 5800 D Performance Award 0 2026-07-01 Common Stock 5800 D These options were awarded under Pro-Dex's 2016 Equity Incentive Plan. The percentage of options that may vest and become exercisable, if any, are 100%, 50%, and 25%, respectively, based upon the volume-weighted average price of Pro-Dex's common stock equaling or exceeding the applicable exercise price for the 60 trading days immediately preceding the date the option becomes exercisable, six months from the date the option becomes exercisable, or twelve months from the date the option becomes exercisable, respectively. These performance awards were awarded under Pro-Dex's 2016 Equity Incentive Plan. Shares of Pro-Dex common stock will be granted to the reporting person in the amounts shown above on the date exercisable shown above, as the vesting criteria for these performance awards have already been satisfied as of the date of this report. EXHIBIT LIST: Exhibit 24 - Power of Attorney /s/ Alisha Charlton, attorny-in-fact pursuant to power of attorney filed herewith 2022-01-06 EX-24 2 domingo_ex24.htm POWER OF ATTORNEY

EXHIBIT 24

POWER OF ATTORNEY

Known all by these present, that the undersigned hereby constitutes and appoints Alisha Charlton in signing singly, the undersigned’s true and lawful attorney-in-fact to:

(1)

execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director and/or 10% owner of Pro-Dex, Inc. (the “Company”) Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(2)

do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(3)

take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact.

IN WITNESS HEREOF, the undersigned has caused this Power of Attorney to be executed as of this 29th day of December, 2021.


/s/ Angelita Domingo		12/29/2021
Signature	Date


Angelita Domingo
Print Name